PSA value—established thresholds for further assessment for prostate cancer (typically >3 ng/mL) or benign enlargement (typically ≥1.5 ng/mL).For clinical decision support tool: continuous variable in ng/mL. This evidence concerns the gene KLK3 and Familial prostate cancer.